Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00550589 | Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus | completed | Phase 2 | 33 | AIDS Malignancy ConsortiumNETWORK | 1 | Dec 21, 2015 | clinicaltrials |
| NCT01022541 | Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer | completed | Phase 2 | 47 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 25, 2015 |
| clinicaltrials |
| NCT01111838 | Clinical and Translational Study of STA-9090 | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00004547 | Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy | completed | Phase 2 | 188 | National Cancer Institute (NCI)NIH | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
| NCT01516489 | Improving Fecal Occult Blood Test Completion Rates Among Veterans | completed | Phase 1 / Phase 2 | 1,549 | Corporal Michael J. Crescenz VA Medical CenterFED | 1 | Oct 26, 2015 | clinicaltrials |
| NCT02575859 | Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients | completed | Phase 1 / Phase 2 | 20 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00103142 | Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | completed | Phase 2 | 74 | Michael Morse, MDOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00402961 | Trial of Acupuncture for Reduction of Post-Colectomy Ileus | completed | Phase 2 | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 17 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT01703910 | Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic | completed | Phase 2 | 29 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT01333475 | MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01356264 | Multimodal Prehabilitation for Colorectal Surgery | completed | Phase 2 | 89 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00689624 | Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer | completed | Phase 2 | 30 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | completed | Phase 2 | 43 | Hoffmann-La RocheINDUSTRY | 1 | Aug 17, 2015 | clinicaltrials |
| NCT02518373 | Effect of G17DT in Patients With Stage II/III Colorectal Cancer(CC5) | completed | Phase 2 | 22 | Cancer Advances Inc.INDUSTRY | 0 | Aug 7, 2015 | clinicaltrials |
| NCT00100841 | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01161316 | Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours(MACRO-2) | completed | Phase 2 | 194 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00052507 | Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01853813 | First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer(CENTRAL) | completed | Phase 2 | 85 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT00890305 | Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone | completed | Phase 2 | 171 | Medivation, Inc.INDUSTRY | 6 | Jul 8, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT01461148 | Vaccination Against MSI Colorectal Cancer | completed | Phase 1 / Phase 2 | 22 | Oryx GmbH & Co. KGINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT00004195 | Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer | completed | Phase 2 | 28 | University of Alabama at BirminghamOTHER | 0 | Jun 15, 2015 | clinicaltrials |
| NCT01131078 | A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 306 | Hoffmann-La RocheINDUSTRY | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00660699 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | completed | Phase 2 | 50 | Washington University School of MedicineOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | completed | Phase 2 | 15 | SCRI Development Innovations, LLCOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01108107 | Neoadjuvant Treatment of Colon Cancer | completed | Phase 2 | 76 | Vejle HospitalOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01110941 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China(SCI-101) | completed | Phase 1 / Phase 2 | 20 | Shen LinOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00522665 | Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer | completed | Phase 1 / Phase 2 | 41 | Hoosier Cancer Research NetworkOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT00778830 | Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)(APEC) | completed | Phase 1 / Phase 2 | 289 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 14, 2015 | clinicaltrials |
| NCT01047475 | A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) | completed | Phase 2 | 72 | Microbio Co LtdINDUSTRY | 1 | May 13, 2015 | clinicaltrials |
| NCT01443377 | Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer(NEOREC-1) | completed | Phase 2 | 48 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT01103479 | Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening | completed | Phase 2 / Phase 3 | 569 | Northwestern UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | completed | Phase 2 | 56 | The First People's Hospital of ChangzhouOTHER | 0 | Apr 22, 2015 | clinicaltrials |
| NCT00230399 | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 15 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT02419677 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00032110 | Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00077298 | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01916239 | Pomegranate Extract Supplementation in Colorectal Cancer Patients(POMEcolon) | completed | Phase 1 / Phase 2 | 60 | National Research Council, SpainOTHER_GOV | 1 | Apr 14, 2015 | clinicaltrials |
| NCT01941953 | Metformin and 5-fluorouracil for Refractory Colorectal Cancer. | completed | Phase 2 | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT01531777 | Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer | completed | Phase 2 | 40 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 3, 2015 | clinicaltrials |
| NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma(SHORE) | completed | Phase 1 / Phase 2 | 17 | 4SC AGINDUSTRY | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00551421 | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2015 | clinicaltrials |
| NCT00958386 | Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)(SPECTRA) | completed | Phase 2 | 61 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01071655 | Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer(SETICC) | completed | Phase 2 | 195 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01126112 | Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer(FRAIL) | completed | Phase 2 | 33 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01215539 | Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients | completed | Phase 2 | 78 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 18, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Dec 21, 2015source: clinicaltrials